Mantle Cell Lymphoma (MCL) Latest Advances

May obesity increase the risk of lymphoma? Insights from genetic evidence.

Journal: Expert review of hematology

Published: October 13, 2025

NCCN Guidelines® Insights: B-Cell Lymphomas 3.2025.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: October 09, 2025

Enterovirus-associated deafness and myositis in an immunocompromised patient with in vivo and in vitro efficacy of intravenous immunoglobulins and remdesivir: Case report.

Journal: Antiviral therapy

Published: October 08, 2025

Real-world characteristics, treatment patterns, and outcomes of patients with mantle cell lymphoma by line of therapy.

Journal: Future oncology (London, England)

Published: October 03, 2025

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma.

Journal: Journal of visualized experiments : JoVE

Published: September 29, 2025

CAR T-Cell Therapy in Cancer: Balancing Efficacy with Cardiac Toxicity Concerns.

Journal: Journal of cancer science and clinical therapeutics

Published: September 29, 2025

Mantle cell lymphoma with hypereosinophilia: A case report and review of the literature.

Journal: Tumori

Published: September 20, 2025

Clinicopathologic Characteristics and Survival Outcome of Patients With Mantle Cell Lymphoma: A North Indian Tertiary Care Center Experience.

Journal: JCO global oncology

Published: September 19, 2025

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs in Japan; nivolumab plus ipilimumab for colorectal cancer, trastuzumab deruxtecan for breast cancer, and acalabrutinib for mantle cell lymphoma.

Journal: International journal of clinical oncology

Published: September 15, 2025

Leveraging BRG1 Driven Ferroptosis Resistance to Overcome Treatment Resistance.

Journal: bioRxiv : the preprint server for biology

Published: September 15, 2025

Prognostic Significance of Endothelial Activation and Stress Index in Mantle Cell Lymphoma

Journal: Zhongguo shi yan xue ye xue za zhi

Published: September 11, 2025

Multifaceted cfDNA profiling in mantle cell lymphoma.

Journal: Blood advances

Published: September 09, 2025

Filters

May obesity increase the risk of lymphoma? Insights from genetic evidence.

May obesity increase the risk of lymphoma? Insights from genetic evidence.

NCCN Guidelines® Insights: B-Cell Lymphomas 3.2025.

NCCN Guidelines® Insights: B-Cell Lymphomas 3.2025.

Enterovirus-associated deafness and myositis in an immunocompromised patient with in vivo and in vitro efficacy of intravenous immunoglobulins and remdesivir: Case report.

Enterovirus-associated deafness and myositis in an immunocompromised patient with in vivo and in vitro efficacy of intravenous immunoglobulins and remdesivir: Case report.

Real-world characteristics, treatment patterns, and outcomes of patients with mantle cell lymphoma by line of therapy.

Real-world characteristics, treatment patterns, and outcomes of patients with mantle cell lymphoma by line of therapy.

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma.

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma.

CAR T-Cell Therapy in Cancer: Balancing Efficacy with Cardiac Toxicity Concerns.

CAR T-Cell Therapy in Cancer: Balancing Efficacy with Cardiac Toxicity Concerns.

Mantle cell lymphoma with hypereosinophilia: A case report and review of the literature.

Mantle cell lymphoma with hypereosinophilia: A case report and review of the literature.

Clinicopathologic Characteristics and Survival Outcome of Patients With Mantle Cell Lymphoma: A North Indian Tertiary Care Center Experience.

Clinicopathologic Characteristics and Survival Outcome of Patients With Mantle Cell Lymphoma: A North Indian Tertiary Care Center Experience.

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs in Japan; nivolumab plus ipilimumab for colorectal cancer, trastuzumab deruxtecan for breast cancer, and acalabrutinib for mantle cell lymphoma.

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs in Japan; nivolumab plus ipilimumab for colorectal cancer, trastuzumab deruxtecan for breast cancer, and acalabrutinib for mantle cell lymphoma.

Leveraging BRG1 Driven Ferroptosis Resistance to Overcome Treatment Resistance.

Leveraging BRG1 Driven Ferroptosis Resistance to Overcome Treatment Resistance.

Prognostic Significance of Endothelial Activation and Stress Index in Mantle Cell Lymphoma

Prognostic Significance of Endothelial Activation and Stress Index in Mantle Cell Lymphoma

Multifaceted cfDNA profiling in mantle cell lymphoma.

Multifaceted cfDNA profiling in mantle cell lymphoma.